Literature DB >> 10531151

High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism.

P Girard1, D Musset, F Parent, S Maitre, C Phlippoteau, G Simonneau.   

Abstract

STUDY
OBJECTIVES: Because specific studies are unavailable, the exact prevalence of detectable "residual" deep venous thrombosis (DVT) in patients with acute pulmonary embolism (PE) is unknown.
DESIGN: Review of clinical records and radiologic documents of consecutive patients.
SETTING: Pulmonary diseases and radiology departments at a university hospital. PATIENTS: All patients hospitalized in the Department of Pulmonary Diseases with a diagnosis of acute PE during a 5-year period (1984 to 1988). During this period, the diagnosis of PE was based exclusively on pulmonary angiography, and bilateral lower limb venography was routine in patients with proven acute PE. MEASUREMENTS AND
RESULTS: Among 228 consecutive patients with angiography-proven PE, 213 underwent bilateral lower limb venography within 48 h of the diagnosis. Venography demonstrated DVT in 174 patients (81.7%; 95% confidence interval, 76.5 to 86.9%), including 128 patients (60%) with proximal DVT. Signs or symptoms of DVT were present in only 72 patients (42%) with DVT. The prevalence of detectable DVT was significantly lower in patients with recent pelvic surgery or delivery (6 of 12, 50%) than in the other patients, whatever their individual risk factors (p < 0.05). The mean pulmonary vascular obstruction was significantly lower in patients with normal venography than in patients with detectable DVT (37.6 +/- 20.9% vs 48.4 +/- 21.7%; p = 0.007).
CONCLUSIONS: Lower limb venography demonstrates a high prevalence (82%) of residual DVT in patients with angiography-proven PE. These data should be taken into account in the diagnostic and therapeutic management of patients with suspected or proven PE.

Entities:  

Mesh:

Year:  1999        PMID: 10531151     DOI: 10.1378/chest.116.4.903

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

1.  Correlation between the site of pulmonary embolism and the extent of deep vein thrombosis: evaluation by computed tomography pulmonary angiography and computed tomography venography.

Authors:  Yosuke Horii; Norihiko Yoshimura; Yoshiro Hori; Satoshi Takaki; Toru Takano; Shoichi Inagawa; Hidefumi Aoyama
Journal:  Jpn J Radiol       Date:  2011-04-26       Impact factor: 2.374

2.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

3.  Investigating pulmonary embolism in the emergency department with lower limb plethysmography: the Manchester Investigation of Pulmonary Embolism Diagnosis (MIOPED) study.

Authors:  K Hogg; D Dawson; K Mackway-Jones
Journal:  Emerg Med J       Date:  2006-02       Impact factor: 2.740

4.  Review of acute pulmonary embolism in a general hospital.

Authors:  Keiichi Ishida; Masahisa Masuda
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

5.  Clinical Significance of the Soleal Vein and Related Drainage Veins, in Calf Vein Thrombosis in Autopsy Cases with Massive Pulmonary Thromboembolism.

Authors:  Ayako Ro; Norimasa Kageyama
Journal:  Ann Vasc Dis       Date:  2015-12-11

6.  [Venous thromboembolism prophylaxis for urological operations].

Authors:  G Lümmen; C Fischer
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

Review 7.  Diagnosis of pulmonary embolism.

Authors:  Clive Kearon
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

8.  Deep vein thrombosis and pulmonary embolism - Prevention, management, and anaesthetic considerations.

Authors:  Krishan Kumar Narani
Journal:  Indian J Anaesth       Date:  2010-01

Review 9.  Diagnosing pulmonary embolism.

Authors:  M Riedel
Journal:  Postgrad Med J       Date:  2004-06       Impact factor: 2.401

Review 10.  When to perform CTA in patients suspected of PE?

Authors:  Benoît Ghaye; Robert F Dondelinger
Journal:  Eur Radiol       Date:  2007-10-05       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.